Dan Lauria

Dan Lauria

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Pirates' Paul Skenes sets MLB record with dominant shutout performance
  • Under Armour's weak Q1 sales and tariff pressures lead to a plunge in its stock price.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Pirates' Paul Skenes sets MLB record with dominant shutout performance
  • Under Armour's weak Q1 sales and tariff pressures lead to a plunge in its stock price.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Dan Lauria